Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial

2001 ◽  
Vol 47 (5) ◽  
pp. 391-396 ◽  
Author(s):  
M. Donadio ◽  
E. Manzin ◽  
A. Berruti ◽  
A. Bottini ◽  
G. Gorzegno ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Multicenter Phase

Gemcitabine/Vinorelbine in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines: Results of a Phase II Trial

2003 ◽  
Vol 4 (1) ◽  
pp. 46-50 ◽  
Author(s):  
F. Lobo ◽  
J.A. Virizuela ◽  
F.J. Dorta ◽  
J. Florián ◽  
M. Lomas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients ◽  
Previously Treated

scholarly journals Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e69256 ◽  
Author(s):  
George Fountzilas ◽  
Vassiliki Kotoula ◽  
Dimitrios Pectasides ◽  
George Kouvatseas ◽  
Eleni Timotheadou ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

2012 ◽  
Vol 35 (1) ◽  
pp. 18-21 ◽  
Author(s):  
Jean-Philippe Jacquin ◽  
Cyrus Chargari ◽  
Julie Thorin ◽  
Dominique Mille ◽  
Adrien Mélis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Breast Cancer Patients

scholarly journals Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations

2021 ◽  
Vol 189 (3) ◽  
pp. 641-651
Author(s):  
Jing Xu ◽  
Tanya E. Keenan ◽  
Beth Overmoyer ◽  
Nadine M. Tung ◽  
Rebecca S. Gelman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document